Prof. Dr. Darius P. Zlotos
Cited by
Cited by
Update on melatonin receptors: IUPHAR Review 20
R Jockers, P Delagrange, ML Dubocovich, RP Markus, N Renault, ...
British journal of pharmacology 173 (18), 2702-2725, 2016
MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential
DP Zlotos, R Jockers, E Cecon, S Rivara, PA Witt-Enderby
Journal of medicinal chemistry 57 (8), 3161-3185, 2014
Recent advances in melatonin receptor ligands
DP Zlotos
Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2005
Discovery of nanomolar dengue and West Nile virus protease inhibitors containing a 4-benzyloxyphenylglycine residue
MAM Behnam, D Graf, R Bartenschlager, DP Zlotos, CD Klein
Journal of medicinal chemistry 58 (23), 9354-9370, 2015
Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and …
S Buller, DP Zlotos, K Mohr, J Ellis
Molecular pharmacology 61 (1), 160-168, 2002
Pharmacological characterisation of strychnine and brucine analogues at glycine and α7 nicotinic acetylcholine receptors
AA Jensen, P Gharagozloo, NJM Birdsall, DP Zlotos
European journal of pharmacology 539 (1-2), 27-33, 2006
Recent progress in the development of agonists and antagonists for melatonin receptors
D P Zlotos
Current medicinal chemistry 19 (21), 3532-3549, 2012
Melatonin receptor ligands: a pharmaco‐chemical perspective
JA Boutin, PA Witt‐Enderby, C Sotriffer, DP Zlotos
Journal of pineal research 69 (3), e12672, 2020
Drug conjugates—an emerging approach to treat breast cancer
M Hasan, RK Leak, RE Stratford, DP Zlotos, PA Witt‐Enderby
Pharmacology research & perspectives 6 (4), e00417, 2018
Bisquaternary Ligands of the Common Allosteric Site of M2 Acetylcholine Receptors:  Search for the Minimum Essential Distances between the Pharmacophoric …
T Nassif-Makki, C Tränkle, D Zlotos, G Bejeuhr, A Cambareri, ...
Journal of medicinal chemistry 42 (5), 849-858, 1999
Pharmacological, mechanistic, and pharmacokinetic assessment of novel melatonin-tamoxifen drug conjugates as breast cancer drugs
M Hasan, MA Marzouk, S Adhikari, TD Wright, BP Miller, MD Matossian, ...
Molecular Pharmacology 96 (2), 272-296, 2019
2-[(2,3-Dihydro-1H-indol-1-yl)methyl]melatonin Analogues: A Novel Class of MT2-Selective Melatonin Receptor Antagonists
DP Zlotos, MI Attia, J Julius, S Sethi, PA Witt-Enderby
Journal of medicinal chemistry 52 (3), 826-833, 2009
N‐Acetyl‐5‐arylalkoxytryptamine Analogs: Probing the Melatonin Receptors for MT1‐Selectivity
C Markl, WP Clafshenkel, MI Attia, S Sethi, PA Witt‐Enderby, DP Zlotos
Archiv der Pharmazie 344 (10), 666-674, 2011
Bisquaternary caracurine V derivatives as allosteric modulators of ligand binding to M2 acetylcholine receptors
DP Zlotos, S Buller, C Tränkle, K Mohr
Bioorganic & medicinal chemistry letters 10 (22), 2529-2532, 2000
Muscarinic receptor agonists and antagonists
DP Zlotos, W Bender, U Holzgrabe
Expert Opinion on Therapeutic Patents 9 (8), 1029-1053, 1999
Synthesis, NMR conformational analysis and pharmacological evaluation of 7, 7a, 13, 14-tetrahydro-6 H-cyclobuta [b] pyrimido [1, 2-a: 3, 4-a′] diindole analogues as melatonin …
MI Attia, D Güclü, B Hertlein, J Julius, PA Witt-Enderby, DP Zlotos
Organic & Biomolecular Chemistry 5 (13), 2129-2137, 2007
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel …
C Markl, MI Attia, J Julius, S Sethi, PA Witt-Enderby, DP Zlotos
Bioorganic & medicinal chemistry 17 (13), 4583-4594, 2009
Probing the Pharmacophore for Allosteric Ligands of Muscarinic M2 Receptors:  SAR and QSAR Studies in a Series of Bisquaternary Salts of Caracurine V and …
DP Zlotos, S Buller, N Stiefl, K Baumann, K Mohr
Journal of medicinal chemistry 47 (14), 3561-3571, 2004
PPAR gamma activators: off-target against glioma cell migration and brain invasion
S Seufert, R Coras, C Tränkle, DP Zlotos, I Blümcke, L Tatenhorst, ...
PPAR research 2008, 2008
Bisquaternary dimers of strychnine and brucine. A new class of potent enhancers of antagonist binding to muscarinic M2 receptors
DP Zlotos, S Buller, U Holzgrabe, K Mohr
Bioorganic & medicinal chemistry 11 (12), 2627-2634, 2003
The system can't perform the operation now. Try again later.
Articles 1–20